Effects of platelet-derived growth factor on the synthesis of lipoprotein lipase in human monocyte-derived macrophages. 1995

T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Lipoprotein lipase (LPL), which is secreted by the two predominant cell types in atherosclerotic plaque, macrophages and smooth muscle cells, may be involved in atherosclerosis by generating atherogenic remnant lipoproteins. We investigated the effects of platelet-derived growth factor (PDGF)-BB on the synthesis of LPL by human monocyte-derived macrophages. These cells were cultured in the presence of PDGF-BB for 8 days, after which the enzyme activity, mass, and mRNA levels of LPL were determined. The effect of PDGF-BB was time-dependent and dose-dependent at concentrations of 1 to 10 ng/mL. At 10 ng/mL PDGF-BB enhanced twofold to 2.3-fold the secretion of LPL, and a pulse-labeling study with [35S]methionine revealed that 10 ng/mL PDGF-BB significantly increased the synthesis of LPL. Northern blotting analysis showed that the LPL mRNA level increased dose dependently in macrophages treated with PDGF-BB, and 10 ng/mL PDGF-BB enhanced twofold the expression of LPL mRNA. The protein kinase C inhibitor staurosporine suppressed the effect of PDGF-BB on LPL activity. These results indicate that PDGF-BB stimulated transcription of the LPL gene in human monocyte-derived macrophages through protein kinase C activation and resulted in an increased synthesis of LPL. Therefore, we hypothesize that the augmented synthesis of LPL by PDGF-BB modulates atherosclerosis by influencing lipoprotein metabolism in the vascular wall.

UI MeSH Term Description Entries
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077214 Becaplermin A recombinant human platelet-derived growth factor B-chain dimer used to promote WOUND HEALING by stimulating PHYSIOLOGIC ANGIOGENESIS. PDGF-BB,Platelet-Derived Growth Factor BB,Platelet-Derived Growth Factor BB, Recombinant,Recombinant Platelet-Derived Growth Factor BB,Regranex,rPDGF-BB,rhPDGF-BB,Platelet Derived Growth Factor BB,Platelet Derived Growth Factor BB, Recombinant,Recombinant Platelet Derived Growth Factor BB
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D020574 Proto-Oncogene Proteins c-sis Cellular DNA-binding proteins encoded by the sis gene (GENES, SIS). c-sis proteins make up the B chain of PLATELET-DERIVED GROWTH FACTOR. Overexpression of c-sis causes tumorigenesis. PDGFB,Platelet-Derived Growth Factor B,c-sis Proteins,sis Proto-Oncogene Proteins,Proto-Oncogene Products c-sis,Proto-Oncogene Protein sis,Proto-Oncogene Proteins sis,Platelet Derived Growth Factor B,Proto Oncogene Products c sis,Proto Oncogene Protein sis,Proto Oncogene Proteins c sis,Proto Oncogene Proteins sis,Proto-Oncogene Proteins, sis,c sis Proteins,sis Proto Oncogene Proteins,sis, Proto-Oncogene Protein,sis, Proto-Oncogene Proteins

Related Publications

T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
February 1996, Biochemical Society transactions,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
January 1985, Scandinavian journal of gastroenterology. Supplement,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
February 1982, The Journal of clinical investigation,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
August 1990, Biochimica et biophysica acta,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
June 1990, Biochimica et biophysica acta,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
February 1998, Biochemical Society transactions,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
April 1988, Biochimica et biophysica acta,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
February 1997, Biochemical Society transactions,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
July 1988, Biochemical and biophysical research communications,
T Inaba, and M Kawamura, and T Gotoda, and K Harada, and M Shimada, and J Ohsuga, and H Shimano, and Y Akanuma, and Y Yazaki, and N Yamada
December 1987, FEBS letters,
Copied contents to your clipboard!